reviewed april 2026|next review october 2026|88 physicians psi has verified|132 published studies
Epitalon
Epitalon (epithalon) is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) developed by Professor Vladimir Khavinson at the Saint Petersburg Institute of Bioregulation and Gerontology, studied for telomerase activation, melatonin stimulation, and lifespan extension in rodent models.
Evidence landscape: 132 published studies
132 published items. 4 human studies and 118 animal studies. Evidence base is internally consistent but concentrated in a single research program without independent Western replication.
- 4 Human
- 118 Animal
- 10 Reviews
The central claim: epitalon activates telomerase reverse transcriptase (hTERT) in human somatic cells. Replicated within the Khavinson program but not by independent Western laboratories.
Virtually all data originates from Professor Vladimir Khavinson's research program at the Saint Petersburg Institute of Bioregulation and Gerontology, spanning four decades.
Anisimov studies report 10-25% lifespan extension in rodent models. Internally consistent results within the originating program.
PSI Assessment
The evidence base for epitalon is defined by a single extraordinary claim from a single research program spanning four decades: that a four-amino-acid peptide can activate telomerase and potentially slow biological aging. Developed by Professor Vladimir Khavinson at the Saint Petersburg Institute of Bioregulation and Gerontology, epitalon has produced internally consistent telomerase activation data, rodent lifespan extension of 10-25%, and small human studies showing improved melatonin production in elderly subjects. Independent Western replication is minimal, and the study designs do not meet current Western clinical trial standards.
Four decades of internally consistent data from one research program. Telomerase activation and rodent lifespan extension of 10-25%. Minimal independent Western replication.
The proposed mechanism is telomerase activation through induction of hTERT (human telomerase reverse transcriptase) gene expression. Telomere shortening is one of the hallmarks of cellular aging, and telomerase is the enzyme that maintains telomere length. Epitalon also stimulates melatonin production from the pineal gland in elderly subjects. The Khavinson bioregulator hypothesis proposes that short peptides bind DNA regulatory regions to modulate gene expression. This mechanism is not widely accepted in Western molecular biology.
What the evidence supports
Epitalon activates telomerase (hTERT) expression in cell culture and animal models, documented across multiple publications from the Khavinson research program. Rodent lifespan extension of 10-25% is internally consistent across studies. Small human studies demonstrate improved melatonin production in elderly subjects. The data is coherent within its own research program.
What is not yet established
Independent Western replication of the telomerase activation claim. Whether the rodent lifespan data translates to humans. Whether the bioregulator mechanism (short peptides binding DNA regulatory regions) is accurate. Long-term safety of telomerase activation, given that telomerase is also active in cancer cells.
Research Evidence
The findings below cover the telomerase activation claim, the rodent lifespan data, and the melatonin restoration effect in elderly subjects.
Evidence by condition
Evidence dimensions across epitalon's investigated conditions. Telomerase activation has the most data, all from the Khavinson program.
| Condition | Mechanism | Animal evidence | Human evidence | Replication |
|---|---|---|---|---|
| Telomerase Activation | ||||
| Circadian/Sleep | ||||
| Aging/Lifespan | ||||
| Immune Function | ||||
| Cancer Research |
Epitalon activates telomerase (hTERT) expression in human somatic cell cultures and animal models. This is the central and most replicated finding within the Khavinson research program. The finding has been reported across multiple publications but has not been independently replicated by Western laboratories.
Telomerase activation in a culture dish and telomere maintenance in a living human are different questions. The translation gap is substantial.
Anisimov and colleagues report rodent lifespan extension of 10-25% across multiple studies from the originating laboratory. The results are internally consistent within the Khavinson program.
All lifespan data comes from the originating lab. The gap between rodent lifespan extension and human longevity benefit is one of the largest in biomedical research.
Small human studies in elderly subjects report improved melatonin production from the pineal gland. The pineal gland connection is the most biologically grounded aspect of epitalon research, since pineal regulation of melatonin is well-established biology.
Whether melatonin normalization from epitalon offers advantages over direct melatonin supplementation is not addressed in the literature.
4 Human|118 Animal|10 Reviews
View all 132 indexed studiesHow Epitalon Works
Epitalon (Ala-Glu-Asp-Gly) is a synthetic tetrapeptide proposed to activate telomerase (hTERT) and stimulate pineal gland melatonin production through the Khavinson bioregulator mechanism.
Every time your cells divide, the protective caps on the ends of your chromosomes (called telomeres) get slightly shorter. When they get too short, the cell can no longer divide and either dies or becomes dysfunctional. Epitalon is studied because it appears to activate telomerase, the enzyme that rebuilds those protective caps, potentially allowing cells to continue dividing normally for longer. It also stimulates melatonin production from the pineal gland, which regulates sleep-wake cycles.
For a more detailed view of the biology, here is what researchers have observed at the molecular level.
Epitalon activates telomerase reverse transcriptase (hTERT) in human somatic cells, the catalytic subunit responsible for adding TTAGGG repeats to chromosome ends. It modulates pineal gland function, increasing melatonin synthesis. The proposed mechanism involves peptide bioregulation of gene expression through direct interaction with DNA regulatory regions. This bioregulator hypothesis is not widely accepted in Western molecular biology.
What is Epitalon being studied for?
Researchers are studying Epitalon across several health conditions. Each condition below is labeled with the strength of evidence that exists for that specific use, not for Epitalon overall. This means a compound can have human studies for one condition but only animal data for another.
Telomerase Activation
·Human TrialsCell culture studies show epitalon activates telomerase (hTERT) in human somatic cells. This is the central and most replicated finding within the Khavinson research program.
Limitations: All telomerase activation data comes from the Khavinson research group. Independent Western replication is absent. Whether activation in cell culture translates to meaningful telomere maintenance in a living human is not established.
Circadian/Sleep
·Animal StudiesEpitalon stimulates melatonin production from the pineal gland. Small human studies in elderly subjects report improved melatonin secretion patterns.
Limitations: Sample sizes are small. Whether melatonin normalization from epitalon offers advantages over direct melatonin supplementation is not addressed.
Aging/Lifespan
·Animal StudiesAnisimov studies report rodent lifespan extension of 10-25%. Small human studies in elderly populations report improved functional health markers.
Limitations: All lifespan data is from the originating lab. No randomized controlled trial meeting Western standards has demonstrated lifespan or healthspan benefits.
Immune Function
·PreclinicalOlder studies using epithalamin (the natural pineal extract from which epitalon is derived) reported improvements in T-cell function and immune markers in elderly patients.
Limitations: Data is primarily from epithalamin rather than synthetic epitalon. Methodology does not meet current standards.
Cancer Research
·PreclinicalSome Khavinson laboratory publications report reduced tumor incidence in aged rodents treated with epitalon. The relationship between telomerase activation and cancer is complex.
Limitations: Telomerase activation could theoretically promote cancer growth, not prevent it. This is the least developed and most speculative research area.
Safety and Regulatory Status
FDA Status: Not FDA-approved for any indication. Not approved by any major Western regulatory authority.
Availability: Currently on the FDA Category 2 list, meaning licensed pharmacies cannot compound it. Expected to become available through licensed pharmacies following regulatory review per the February 2026 HHS announcement.
Safety Profile: No serious adverse events reported in published human studies from the Khavinson program. The total human safety database is small and comes primarily from one research group.
The safety profile appears favorable based on published studies, but the total human safety database is small. The theoretical relationship between telomerase activation and cancer risk is an unresolved concern.
Peptide Structure
Technical molecular data for researchers and clinicians.
Questions and Comparisons
Questions the evidence raises for a Epitalon discussion.
Comparison and Related Research
Epitalon is most often compared with the copper tripeptide GHK-Cu (different longevity mechanism), Thymosin Alpha-1 (Western-validated immune peptide), and Pinealon (another Khavinson bioregulator).
Head-to-head comparisons
Full research comparisons covering Epitalon and another peptide side by side.
Epitalon vs GHK-Cu
Both target aging through different mechanisms. Epitalon works on telomeres. GHK-Cu works on collagen and skin. Evidence-graded comparison of two Animal Studies anti-aging peptides.
View full comparisonRelated compounds
Frequently Asked Questions
References
Each citation links to the original study on PubMed, the U.S. National Library of Medicine database.
- 1.Laboratory study demonstrating that epitalon (Epithalon) activated telomerase and increased telomere length in cultured human cells. Telomeres are protective caps on chromosomes that shorten with age, and this finding suggested a potential mechanism for the anti-aging effects observed in earlier animal studies.Khavinson VKh et al., 2003 in Bull Exp Biol Med. View on PubMed
- 2.Evaluated the lifespan effects of epithalamin (the pineal peptide preparation containing epitalon) across three species. Treatment extended maximum lifespan in fruit flies, mice, and rats, providing consistent cross-species evidence for longevity effects.Anisimov VN et al., 1998 in Mech Ageing Dev. View on PubMed
- 3.Examined the antioxidant effects of epithalamin in both human subjects and animal models. The study found reduced markers of oxidative stress, suggesting the peptide may help counteract free-radical damage associated with aging.Anisimov VN et al., 2001 in Neuro Endocrinol Lett. View on PubMed
- 4.Comprehensive review of peptide bioregulator research spanning two decades, including epitalon and related pineal peptides. Summarized evidence across cell culture, animal, and limited human studies supporting potential anti-aging applications of short regulatory peptides.Khavinson VKh et al., 2010 in Vestn Ross Akad Med Nauk. View on PubMed
Medical Disclaimer
This content is for educational and informational purposes only and does not constitute medical advice. The information presented reflects published research as indexed by PSI and should not be used to make treatment decisions. Always consult a qualified healthcare provider before starting, stopping, or modifying any treatment.